STXS Stereotaxis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: STXS

Price (delayed)

$2.56

Market cap

$210.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.27

Enterprise value

$195.18M

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic ...

Highlights
Stereotaxis's debt has decreased by 6% YoY
STXS's equity is down by 38% year-on-year and by 13% since the previous quarter
STXS's quick ratio is down by 24% YoY and by 15% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.stereotaxis.com
Peers: BSX EW ATRC JNJ

Key stats

What are the main financial stats of STXS
Market
Shares outstanding
82.13M
Market cap
$210.25M
Enterprise value
$195.18M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
12.67
Price to sales (P/S)
7.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.29
Earnings
Revenue
$26.77M
EBIT
-$20.71M
EBITDA
-$20.09M
Free cash flow
-$9.51M
Per share
EPS
-$0.27
Free cash flow per share
-$0.12
Book value per share
$0.2
Revenue per share
$0.33
TBVPS
$0.52
Balance sheet
Total assets
$41.91M
Total liabilities
$19.99M
Debt
$5.49M
Equity
$16.34M
Working capital
$20.02M
Liquidity
Debt to equity
0.34
Current ratio
2.51
Quick ratio
1.84
Net debt/EBITDA
0.75
Margins
EBITDA margin
-75%
Gross margin
55.5%
Net margin
-77.4%
Operating margin
-81.6%
Efficiency
Return on assets
-47.6%
Return on equity
-110.1%
Return on invested capital
-105.1%
Return on capital employed
-72.3%
Return on sales
-77.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STXS stock price

How has the Stereotaxis stock price performed over time
Intraday
2.4%
1 week
-3.03%
1 month
1.99%
1 year
43.82%
YTD
46.29%
QTD
-1.92%

Financial performance

How have Stereotaxis's revenue and profit performed over time
Revenue
$26.77M
Gross profit
$14.86M
Operating income
-$21.84M
Net income
-$20.71M
Gross margin
55.5%
Net margin
-77.4%
STXS's operating margin is down by 22% YoY and by 15% from the previous quarter
Stereotaxis's gross profit has decreased by 20% YoY and by 10% from the previous quarter
Stereotaxis's net margin has decreased by 19% YoY and by 15% from the previous quarter
STXS's operating income is down by 16% year-on-year and by 4% since the previous quarter

Growth

What is Stereotaxis's growth rate over time

Valuation

What is Stereotaxis stock price valuation
P/E
N/A
P/B
12.67
P/S
7.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.29
The EPS has contracted by 3.8% YoY
STXS's P/B is 84% above its last 4 quarters average of 6.9 and 32% above its 5-year quarterly average of 9.6
STXS's equity is down by 38% year-on-year and by 13% since the previous quarter
The stock's price to sales (P/S) is 58% more than its last 4 quarters average of 4.9 but 17% less than its 5-year quarterly average of 9.3
STXS's revenue is down by 9% from the previous quarter and by 4.9% YoY

Efficiency

How efficient is Stereotaxis business performance
Stereotaxis's return on equity has shrunk by 63% YoY and by 17% QoQ
Stereotaxis's ROA has decreased by 36% YoY and by 11% from the previous quarter
STXS's return on invested capital is down by 33% since the previous quarter and by 12% year-on-year
The ROS has contracted by 19% YoY and by 15% from the previous quarter

Dividends

What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STXS.

Financial health

How did Stereotaxis financials performed over time
The company's total assets is 110% higher than its total liabilities
STXS's quick ratio is down by 24% YoY and by 15% QoQ
The company's total assets fell by 22% YoY and by 6% QoQ
Stereotaxis's debt is 66% less than its equity
STXS's debt to equity has soared by 55% year-on-year and by 13% since the previous quarter
STXS's equity is down by 38% year-on-year and by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.